Swiss health insurance premiums could increase by 5 percent as pharmaceutical companies and the federal government dispute proposed savings measures for medication costs.

Approximately 90,000 Finns used semaglutide for obesity last year, with Finns spending 66 million of their own money on obesity medications, while pharmaceutical companies' attempts to get obesity drugs covered by Kela reimbursements have been unsuccessful.

Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million, while Compass Therapeutics also announced a net loss of $18.3 million for the same quarter. Both pharmaceutical companies disclosed their financial results.

Biopharmaceutical companies are exploring partnerships and research and development opportunities in China and other international markets.

Specialists in Moldova are increasingly debating changes to pharmaceutical market legislation, questioning whether current laws protect the interests of patients or individual pharmaceutical companies and aiming to prevent monopolies.

Conspiracy theories regarding the Hantavirus are rapidly spreading across the internet, linking the virus to various entities from pharmaceutical companies and The Simpsons to Bill Gates and Jeffrey Epstein. These theories are gaining traction despite a low number of actual infections.

France's National Agency for the Safety of Medicine and Health Products (ANSM) has sanctioned pharmaceutical companies Novo Nordisk and Eli Lilly, ruling that their 'awareness initiatives' were in fact covert product promotions.

An article from The Daily Star discusses the critical role of responsibility in the leadership of pharmaceutical companies, likely emphasizing ethical practices and industry accountability.

A new global report by PatientViewTM, "Corporate Reputation of Pharmaceutical Products, 2025/2026," indicates a decline in the reputation of pharmaceutical companies, particularly those perceived as distant from patients during challenging times.

Pharmaceutical companies Novo Nordisk and Eli Lilly have been fined hundreds of thousands of euros for failing to comply with advertising restrictions for prescription-only anti-obesity medications.

Pharmaceutical companies in Germany are expressing strong opposition to Minister Warken's proposed health reforms, warning that the changes could prevent new medications from reaching patients and lead to job losses.

Indian pharmaceutical companies are significantly impacting the global weight loss drug market by introducing generic versions that reduce treatment costs by up to 70 percent.

Pharmaceutical companies Amgen and AstraZeneca have begun real-time drug trials, coinciding with the FDA's use of artificial intelligence to speed up drug development.

An analysis explores whether Bristol Myers Squibb represents the best value investment among major pharmaceutical companies. The article likely delves into the company's financials, pipeline, and market position.

Analysts are assessing the investment potential of several healthcare and pharmaceutical companies, including Eli Lilly, IGC Pharma, and 60 Degrees Pharmaceuticals. They are providing insights and recommendations for investors considering these stocks.

Seventeen major pharmaceutical companies have agreed to participate in a US initiative aimed at reducing the cost of prescription medications.

China's State Council has published new guidelines on innovative drug pricing, described by analysts as the most significant in a decade. The new rules aim to reward drug innovation and ease pricing tensions for both domestic and multinational pharmaceutical companies.

An article argues that the pursuit of a cancer cure should not be constrained by the interests and influence of large pharmaceutical companies.

The Hellenic Association of Pharmaceutical Companies (SFEE) expressed disappointment with Greece's investment clawback decree for 2026–2027, stating that none of their proposals were included and that it hinders innovation.

Artificial intelligence is being leveraged by pharmaceutical companies to reduce the time and cost of drug development by up to 35%, offering a solution to the ongoing patent crisis.

Health Secretary Teodoro Herbosa announced that pharmaceutical companies in the Philippines have committed to not increasing medicine prices until June, citing stability in prices and inventory despite the ongoing Middle East crisis.

The European Union has given its clearance for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus.

Holly Springs, North Carolina, is attracting pharmaceutical companies with features that once characterized Switzerland, transforming North Carolina from America's poorest state to its most business-friendly.

China has given its approval for an innovative breast cancer therapy developed jointly by pharmaceutical companies Daiichi Sankyo and AstraZeneca, expanding treatment options for patients.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, which is expanding Zepbound access, along with Novo Nordisk and Novartis.

Pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute for the fourth consecutive year.

Chinese contract drug makers – including WuXi AppTec, WuXi Biologics and WuXi XDC – face a less certain long-term revenue outlook as US pharmaceutical companies bring production in-house and reconfigure supply chains amid rising US-China tensions. While near-term earnings remained largely locked in, visibility beyond that was limited, according to Cui Cui, head of healthcare research for Asia at Jefferies. “Earnings visibility for 2026 and 2027 is still very strong – revenue momentum is large...

The director of the newspaper Página Um has been acquitted of defamation charges, with the court deeming the accusation 'totally unfounded' in a case stemming from articles about alleged financial links between doctors and pharmaceutical companies during the Covid-19 pandemic.

Subscribe to the "Kapital Zdrave" newsletter here to follow the most current processes in the health sector.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Indian pharmaceutical companies Eris Lifesciences and Natco Pharma have entered into an agreement concerning the drug Semaglutide.

Multiple biotech and pharmaceutical companies, including Legend Biotech, Corcept Therapeutics, and Ultragenyx, have released updates on their drug pipelines, clinical trial data, and regulatory interactions, impacting market outlook.

The Greek Red Cross (EES) and the Association of Pharmaceutical Companies of Greece (SFEE) have joined forces once again through the 'proSFEERoume' social initiative to support and promote health for vulnerable social groups in Lefkada.

Six biopharmaceutical companies and academic teams are currently working on developing antivirals, monoclonal antibodies, and vaccines to combat various strains of hantavirus.

During a parliamentary session, Greek MP Pavlos Polakis criticized pharmaceutical companies, stating that the "innovation fund" leads to increased profits for them and highlighting the problem of clawback.

Indian pharmaceutical companies are reportedly fueling a severe opioid and 'zombie drug' addiction crisis across Africa, particularly in West Africa. This issue persists despite ongoing crackdowns aimed at curbing the illicit drug trade.

Experts are raising concerns about direct-to-consumer pharmaceutical companies using memes and clear messaging to target young men with erectile dysfunction medication ads on social media, noting that many may not actually need the drugs.

As pharmaceutical companies develop more potent obesity drugs, new studies are being published to investigate their potential effects on bone density. This research aims to understand the broader health implications of these medications.

A report claims that a bill from the Greek Ministry of Health was ordered by the US Embassy. It alleges that Ms. Gilfoyle promised US interests she would pressure ministers, citing US pharmaceutical companies' profit losses from clawback policies.

The French drug safety agency ANSM has fined pharmaceutical companies Novo Nordisk and Eli Lilly for advertisements related to weight management drugs in France.

Successful negotiations between the Greek public sector and pharmaceutical companies have ensured that no immunotherapies will be withdrawn from Greece in 2026.

The FDA has proposed excluding weight loss drugs from Novo and Lilly from the bulk compounding list, a move that would benefit the pharmaceutical companies.

Following a record-breaking year, global pharmaceutical companies are actively seeking more biotechnology deals and partnerships within China's burgeoning biotech sector.

Advances are transforming cancer treatment, but questions are being raised about whether major pharmaceutical companies can afford to implement these revolutionary changes. The financial implications of new therapies pose a significant challenge for the industry.

Pharmaceutical companies in the UAE are taking steps to ensure a consistent and steady supply of medicines across the country.

Argentina has developed a more affordable biosimilar version of a leading cancer drug, a move attributed to strict patent regulations that are now being observed by pharmaceutical companies and states globally.

China has announced the suspension of colchicine imports from two specific Indian pharmaceutical companies, citing undisclosed reasons.

Health insurers are raising questions about a new Medicare program that will offer GLP-1 medications to seniors for $50 per month, leading to a drop in shares for pharmaceutical companies like Novo Nordisk and Eli Lilly amid concerns over coverage plans.

The Hellenic Association of Pharmaceutical Companies (SFEE) has launched "Innovation Meets Industry," a new strategic platform aimed at enhancing innovation within the pharmaceutical sector in Greece.

Major pharmaceutical companies are focusing on smaller deals, a strategic shift that is proving advantageous for the biotechnology sector.

Major pharmaceutical companies are increasingly turning their attention to China as a source for the newest drug ideas and innovations.

The Hellenic Association of Pharmaceutical Companies (SFEE) expressed deep concern and disappointment over the disregard of its positions and arguments regarding the significant clawback policy.

Pharmaceutical companies in Portugal are reportedly considering withdrawing from Valormed, the entity responsible for managing needle and lancet waste. This comes as the Environment Agency states Valormed is not meeting European targets, potentially suspending the creation of a new management entity.

Poolbeg Pharma's CEO stated that the recent patent win for POLB-001 significantly strengthens the company's potential for partnerships with major pharmaceutical companies.

FBI Director Kash Patel announced a major crackdown, 'Operation Box Cutter,' which has led to the indictment of Chinese pharmaceutical companies for allegedly supplying fentanyl precursors to the Gulf cartel.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, Novo Nordisk, and Novartis.

Startups are actively working on commercial space stations, envisioning opportunities for pharmaceutical companies and wealthy tourists following the International Space Station's retirement in 2030.

For the fourth consecutive year, pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute.

Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list took effect on Monday, reflecting the sector’s growing role on the international stage. Foreign capital, however, remained cautious, analysts said. “Mainland buyers have been the main force behind the latest healthcare rally. They tend to chase smaller-cap names where a tight free float makes it easi...

A report highlights notable healthcare headlines for the week, focusing on developments related to pharmaceutical companies Viatris, Novo Nordisk, and Gilead Sciences.

The European market is experiencing an influx of medicines produced in Asia, particularly from China, which poses a significant threat to drug security and creates growing competition for European pharmaceutical companies, including those in Poland.

The FDA has released new guidance aimed at speeding up the development process for pharmaceutical companies working on treatments for rare diseases, potentially benefiting the sector.

A new report suggests that weight-loss medications produced by pharmaceutical companies Lilly and Novo Nordisk may have an unexpected benefit, showing a link to the stalling of cancer progression.

A report reveals that pharmaceutical companies in Portugal take nine months to submit new medicines for evaluation, while Infarmed, the national health authority, takes an additional 11 months to decide on their funding, impacting access to new treatments.

The Hellenic Association of Pharmaceutical Companies (SFEE), in collaboration with Industry Disruptors – Game Changers (ID-GC), held the second roundtable of their strategic initiative "Innovation Meets Industry," focusing on investments, startups, and innovation in healthcare.

Greek Health Minister Adonis Georgiadis dismissed claims of pressure from US pharmaceutical companies regarding the creation of an Innovation Fund, calling them "conspiracy theories" during a parliamentary discussion.

Concerns are being raised about the excessive profits of pharmaceutical companies, alongside criticism that hospitals are severely understaffed, with one hospital handling over 100,000 emergency cases with only two pathologists.

Bristol Myers Squibb and China's Hengrui Pharma have signed a licensing deal valued at up to $15.2 billion. This agreement involves a significant collaboration between the two pharmaceutical companies.

A drug regulator has instructed pharmaceutical companies to submit safety reports for new drugs starting from their actual launch date, aiming to enhance post-market surveillance.

The PatientView™ annual global survey, 'The Corporate Reputation of Pharma' 2025/2026, reveals how patient support influences the reputation of pharmaceutical companies, based on responses from 2,403 patient groups.

French regulators have issued fines to pharmaceutical companies Novo Nordisk France and Lilly France for advertising anti-obesity treatments to the general public, which is prohibited under French law.

An analysis provides insights into the performance and outlook of several pharmaceutical giants, highlighting Bristol Myers' legacy boost, Biogen's positive prospects, and Regeneron's uncertain future.

Pharmaceutical companies Lilly and Novo Nordisk saw their stock prices increase following a proposal from the FDA to exclude GLP-1 receptor agonists from the compounding list.

The FTSE 100 index closed lower, primarily impacted by the struggles and declining share prices of major pharmaceutical companies GSK and AstraZeneca.

Chinese drug maker WuXi AppTec announced record first-quarter revenue, driven by a robust order backlog and sustained demand from pharmaceutical companies worldwide. The company's growth was supported by its strong global market presence.

Dozens of UK Members of Parliament are opposing Health Secretary Wes Streeting's move to grant himself power to dictate NHS drug prices, raising concerns about legality and potential benefits for big pharmaceutical companies.

Beijing Tongren Hospital has sold an ophthalmic dataset to pharmaceutical companies, indicating a trend in data monetization within the healthcare sector.

Pharmaceutical companies Teva and NeuroGen have announced a partnership to develop and distribute a migraine drug in the Chinese mainland market.

Pharmaceutical companies Merck and Eisai have encountered a setback in a late-stage clinical trial for their Keytruda regimen, intended for the treatment of kidney cancer.

Germany is reportedly losing a significant portion of newly approved drugs to the USA, with pharmaceutical companies preferring to launch new therapies there due to the financial impact of health reforms in Germany.

Pharmacists in Malaysia are urging for the establishment of buffer stocks and increased local production to ensure the nation's medicine supply, following new reporting requirements for pharmaceutical companies.

A conflict has emerged in Portugal between the Environment Agency (APA) and pharmaceutical companies regarding the disposal of medical needle waste. The industry claims the situation blocks operations and risks a company's viability, while APA defends its legal framework.

The European Union has granted approval for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus, clearing a major regulatory hurdle for the deal.

Major pharmaceutical companies involved with COVID vaccines were compelled to discontinue a new research study because of insufficient participant enrollment.

Cross-border outlicensing activities by Chinese biotech firms reached a record US$60 billion in the first quarter of 2026, driven by multinational pharmaceutical companies' growing interest in the country's promising drug candidates.

Indian pharmaceutical companies are pursuing an aggressive strategy to enter European markets with generic products, capitalizing on Europe's push for greater autonomy in drug supply, according to Aneta Grzegorzewska of Ged.

An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.

Swiss-based Syngenta announced plans to build a new $120 million agricultural science center in the UK, an investment that contrasts with pharmaceutical companies withdrawing funding from British research facilities.

International pharmaceutical companies are expanding their operations and presence in the United States, a strategic move influenced by the looming threat of tariffs.

Hong Kong-listed mainland Chinese pharmaceutical companies are projected to achieve full-year profits, driven by increasing drug sales and successful out-licensing deals with global partners.

Poland's Ministry of Health is advocating for drug sovereignty by supporting the refunding of domestically produced medicines and offering incentives to pharmaceutical companies that relocate production to Poland, aiming to enhance drug security.

Delays in pricing and reimbursement processes continue to negatively affect the revenue streams of biopharmaceutical companies.